Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Shashi Kumar Nagaraj
Professor Emeritus of Pediatrics
Pediatrics, Nephrology
shashi.nagaraj@duke.edu
2301 Erwin Rd, Durham, NC 27710
2301 Erwin Rd, Durham, NC 27710
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
Professional Training and Employment
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Single arm Study of ALXN1210 in Complement Inhibitor Treatment-Naive Adult and Adolescent Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical Trial
Principal Investigator ·
Awarded by Alexion Pharmaceuticals, Inc. ·
2017 - 2022
A PHASE 3, OPEN-LABEL, MULTICENTER STUDY OF ALXN1210 IN CHILDREN AND ADOLESCENTS WITH ATYPICAL HEMOLYTIC-UREMIC SYNDROME (aHUS)
Clinical Trial
Principal Investigator ·
Awarded by Alexion Pharmaceuticals, Inc. ·
2017 - 2020
Vifor PA21 Phaslyra
Clinical Trial
Principal Investigator ·
Awarded by Vifor Fresenius Medical Care Renal Pharma ·
2016 - 2019
An observational, non-interventional, multi-center, multi-national study of patients with Atypical Hemolytic-Uremic Syndrome (aHUS Registry)
Clinical Trial
Principal Investigator ·
Awarded by Alexion Pharmaceuticals, Inc. ·
2013 - 2018
